Literature DB >> 7239516

Chromosomal investigations in epileptic children during long-term therapy with phenytoin or primidone.

K J Esser, F Kotlarek, M Habedank, U Mühler, E Mühler.   

Abstract

In epileptic children the long-term therapy with anticonvulsant drugs is absolutely necessary. However, anticonvulsant drugs have been suspected to be mutagenic and teratogenic. To investigate this problem metaphase chromosome observations were performed using short-time culture of peripheral blood lymphocytes from twenty children. Ten of the children had been treated with phenytoin and the other ten with primidone on monotherapy. The long-term administration of anticonvulsant drugs was monitored by measurement of the serum concentrations of phenytoin and primidone, by seizure anamnesis, and by repeated EEG investigations. Analyzing 100 mitoses from each proband, we found no increase of structural or numerical aberrations in our patients compared with six controls. In adults, however, anticonvulsant drugs have been found to cause structural aberrations and chromosomal damage. The absence of these lesions in children may reflect the higher efficiency of DNA-repair in local DNA-damage.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7239516     DOI: 10.1007/bf00274690

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  10 in total

1.  Nonrandom distribution of chromosome breaks in cultured lymphocytes of normal subjects.

Authors:  S Aymé; J F Mattei; M G Mattei; Y Aurran; F Giraud
Journal:  Hum Genet       Date:  1976-02-29       Impact factor: 4.132

2.  [Gerontological investigations of the nucleic acid metabolism in the rat. II. DNA repair capacity in different ages (authors transl)].

Authors:  H Niedermüller; G Hofecker; A Kment
Journal:  Aktuelle Gerontol       Date:  1978-05

3.  The human leukocyte test system. I. DNA synthesis and mitoses in PHA-stimulated 2-day cultures.

Authors:  G Dudin; B Beek; G Obe
Journal:  Mutat Res       Date:  1974-05       Impact factor: 2.433

4.  [Chromosome studies in persons treated with anticonvulsant drugs].

Authors:  K P Grosse; G Schwanitz; H D Rott; H F Wissmüller
Journal:  Humangenetik       Date:  1972

5.  [Cytogenetic effects of anticonvulsants. Apropos of an observation of abnormalities transmitted during intra-uterine life].

Authors:  N Ayraud; J Kermarec; J Martinon
Journal:  Ann Genet       Date:  1968-12

6.  Chromosomal analyses of bone marrow and peripheral blood in subjects with a history of illicit drug use.

Authors:  A P Amarose; C R Schuster
Journal:  Arch Gen Psychiatry       Date:  1971-08

7.  Chromosomal investigations in children with pyknolepsy on dipropylacetate monotherapy.

Authors:  F Kotlarek; J Faust
Journal:  Hum Genet       Date:  1978-09-19       Impact factor: 4.132

8.  Proceedings: Cytogenetic testing of antiepileptic drugs in human patients.

Authors:  H D Bartsch
Journal:  Mutat Res       Date:  1975-08       Impact factor: 2.433

9.  Cytogenetic studies in control men and women. I. Variations in aberration frequencies in 29,709 metaphases from 305 cultures obtained over a three-year period.

Authors:  L G Littlefield; K O Goh
Journal:  Cytogenet Cell Genet       Date:  1973

10.  Chromosomal damage in epileptics on monotherapy with carbamazepine and diphenylhydantoin.

Authors:  J Herha; G Obe
Journal:  Hum Genet       Date:  1976-12-15       Impact factor: 4.132

  10 in total
  3 in total

1.  Increased chromosomal breakage in epileptic children after long-term treatment.

Authors:  P Curatolo; V Brinchi; R Cusmai; P Vignetti; P Benedetti
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

2.  Increased sister chromatid exchanges in epileptic children during long-term therapy with phenytoin.

Authors:  M Habedank; K J Esser; D Brüll; F Kotlarek; C Stumpf
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

3.  Chromosome fragile sites in mentally retarded males: increased incidence with seizures and diphenylhydantoin therapy.

Authors:  K B Hodges; R S Larson; M G Butler
Journal:  Ann Clin Lab Sci       Date:  1998 Sep-Oct       Impact factor: 1.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.